You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Treatments for Bipolar Depression: Where We Are and Where We Are Going

  • Authors: Trisha Suppes, MD, PhD; Joseph F. Goldberg, MD
  • CME / CE Released: 2/4/2022
  • Valid for credit through: 2/4/2023
Start Activity

Target Audience and Goal Statement

This activity is intended for psychiatrists, nurses, nurse practitioners, physicians assistants in psychiatry, and other clinicians who treat patients with bipolar depression. 

The goal of this activity is to improve the diagnosis and treatment of patients with bipolar depression.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • FDA approved status of medications for bipolar depression
    • Differences in mechanisms of action among current and emerging treatments for bipolar depression
    • Clinical data on emerging treatments for bipolar depression


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Trisha Suppes, MD, PhD

    Professor, Psychiatry and Behavioral Sciences
    Stanford University School of Medicine
    Stanford, California
    Director, CSP NODES Program
    VA Palo Alto Health Care System
    Palo Alto, California


    Disclosure: Trisha Suppes, MD, PhD, has the following relevant financial relationships:
    Advisor or consultant for: Impel NeuroPharma Inc.; Intracellular Therapies; Sunovion Pharmaceuticals, Inc.
    Speaker or a member of a speakers bureau for: Servier (Australia); Sunovion Pharmaceuticals, Inc.
    Grants for clinical research from: Merck

  • Joseph F. Goldberg, MD

    Professor of Psychiatry
    Icahn School of Medicine at Mount Sinai
    New York, New York


    Disclosure: Joseph F. Goldberg, MD, has the following relevant financial relationships:
    Advisor or consultant for: BioXcel; Jazz Pharmaceuticals; Lundbeck; Otsuka; Sage Pharmaceuticals; Sunovion
    Speaker or a member of a speakers bureau for: AbbVie; Alkermes; Sunovion


  • Clinton W. Wright, PharmD, BCPP

    Medical Education Director, Medscape, LLC


    Disclosure: Clinton W. Wright, PharmD, BCPP, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Treatments for Bipolar Depression: Where We Are and Where We Are Going

Authors: Trisha Suppes, MD, PhD; Joseph F. Goldberg, MDFaculty and Disclosures

CME / CE Released: 2/4/2022

Valid for credit through: 2/4/2023


A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print